EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy-Reference-Cited by-同舟云学术

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

Published:2014-10-21 Issue:23 Volume:5 Page:12189-12202
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Fang Wenfeng¹²,Zhang Jianwei³,Hong Shaodong¹²,Zhan Jianhua¹²,Chen Nan⁴,Qin Tao¹²,Tang Yanna⁴,Zhang Yaxiong¹²,Kang Shiyang¹²,Zhou Ting¹²,Wu Xuan¹²,Liang Wenhua¹²,Hu Zhihuang¹²,Ma Yuxiang¹²,Zhao Yuanyuan¹²,Tian Ying¹²,Yang Yunpeng¹²,Xue Cong¹²,Yan Yue¹²,Hou Xue¹²,Huang Peiyu¹²,Huang Yan¹²,Zhao Hongyun¹²,Zhang Li¹²

Affiliation:

1. State Key laboratory of Oncology in South China, Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China

2. Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

3. Department of Oncology, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

4. Department of Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 328 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDM2 inhibitors in cancer immunotherapy: Current status and perspective;Genes & Diseases;2024-11

2. A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer;Cancers;2024-09-01

3. Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma;Cell Reports Medicine;2024-06

4. Exploring Natural Compounds Targeting PD-L1 and STAT3: Toxicogenomic Analysis, Virtual Screening, Molecular Docking, ADMET Evaluation, and Biological Activity Prediction;Current Computer-Aided Drug Design;2024-05-28

5. Regulatory mechanisms of PD-1/PD-L1 in cancers;Molecular Cancer;2024-05-18